Financial result

Fuller, Smith & Turner PLC: Share Buyback Programme

Retrieved on: 
Monday, December 25, 2023
London Stock Exchange, Listing Rules, ANY, Annual, Common stock, LAWS, Financial result, Security (finance)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

Key Points: 
  • NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.
  • This is consistent with the Company’s capital allocation framework and reflects the Board’s view that the current share price continues to represent a significant discount to the Company’s underlying net asset value.
  • The Programme is expected to enhance earnings per share.
  • Any market purchase of ‘A’ Ordinary Shares under the Programme will be announced no later than 7:30 a.m. on the business day following the day on which the purchase occurred.

Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Thursday, November 16, 2023
Alpha Sigma Tau, Carcinoma, Pancreatic cancer, Neck, Liver disease, Safety, Financial result, Food, Toxicity, Hadassah Medical Center, Clinical trial, Government, Radiation, Patient, FDA, PMDA, Marketing, G&A, Restart, Lung cancer, Lawrence, Massachusetts, Trial of the century, Manager, Financial toxicity, Alpha, Coronavirus Scientific Advisory Board, Itch, Brain, Pharmaceutical industry, Medical imaging

JERUSALEM, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, reported third quarter 2023 financial results and provided a corporate update.

Key Points: 
  • - Treated the first patient with advanced inoperable pancreatic cancer at Hadassah Medical Center in Israel in September, alongside safety and feasibility trial in similar indication currently underway in Montreal, Canada -
    JERUSALEM, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, reported third quarter 2023 financial results and provided a corporate update.
  • Planning treatment of the first patient in the Canadian liver metastases safety and feasibility trial in Q4 2023 or Q1 2024.
  • As of September 30, 2023, the Company had cash, restricted cash, deposits and restricted deposits in the amount of $90.1 million, compared to $105.4 million on December 31, 2022.
  • The Company expects that this cash balance will be sufficient to fund operations for at least two years.

XPENG Reports Third Quarter 2023 Unaudited Financial Results

Retrieved on: 
Wednesday, November 15, 2023
Three Months, Financial result, Investment, Volkswagen Group, ADS, Research, XPENG, ESG, Total, Growth, ADAS, EV, Loss, Robotics, G6, Video game, Food delivery, Cryptocurrency, Clothing, Beauty salon, Insurance, Internet service provider, MSCI

Unaudited Financial Results for the Three Months Ended September 30, 2023

Key Points: 
  • Unaudited Financial Results for the Three Months Ended September 30, 2023
    Total revenues were RMB8.53 billion (US$1.17 billion) for the third quarter of 2023, representing an increase of 25.0% from RMB6.82 billion for the same period of 2022 and an increase of 68.5% from RMB5.06 billion for the second quarter of 2023.
  • Gross margin was negative 2.7% for the third quarter of 2023, compared with 13.5% for the same period of 2022 and negative 3.9% for the second quarter of 2023.
  • Basic and diluted net loss per ADS were both RMB4.49 (US$0.62) for the third quarter of 2023, compared with RMB2.77 for the third quarter of 2022 and RMB3.25 for the second quarter of 2023.
  • Non-GAAP basic and diluted net loss per ADS were both RMB3.23 (US$0.44) for the third quarter of 2023, compared with RMB2.59 for the third quarter of 2022 and RMB3.10 for the second quarter of 2023.

OMNIQ ANNOUNCES Q3 2023 REVENUE OF $17.5 MILLION AND INCREASED GROSS PROFIT to 23%.

Retrieved on: 
Monday, November 13, 2023
EBITDA, Internet of things, Financial result, El Salvador International Airport, Depreciation, Food, Artificial intelligence, Tadiran Telecom, Supply chain, G&A, Automation, Partnership, Growth, Tax, Hospital, AI, Machine vision, Interest, MOD, Restaurant, Customer service, Video game, Clothing, Retail, Cryptocurrency, Pharmaceutical industry, Reinsurance, Bookkeeping, Q3

SALT LAKE CITY, Nov. 13, 2023 (GLOBE NEWSWIRE) -- OMNIQ Corp. (NASDAQ: OMQS) (“OMNIQ” or the “Company”), a provider of Artificial Intelligence (AI) and IoT – based solutions announces Q3 2023 revenue of $17.5M and Gross Profit of $4M.

Key Points: 
  • SALT LAKE CITY, Nov. 13, 2023 (GLOBE NEWSWIRE) -- OMNIQ Corp. (NASDAQ: OMQS) (“OMNIQ” or the “Company”), a provider of Artificial Intelligence (AI) and IoT – based solutions announces Q3 2023 revenue of $17.5M and Gross Profit of $4M.
  • Q3 2023 Revenue of $17.5 Million a 35% decrease vs Q3 2022 impacted by temporary delay of several large orders mainly related to the supply chain line of products.
  • Gross margin for the three months ended September 30, 2023, sequentially increased to 23% as compared to 19% in in Q2 2023 and 21% in Q1 2023.
  • Gross margin for Q3 2023 improved to 23% as compared with 22% in Q3 2022.

Edible Garden Reports 19.4% Year-Over-Year Revenue Growth for Third Quarter of 2023

Retrieved on: 
Monday, November 13, 2023
Cream, Ice cream, St. Raphael's Edible Garden, Dierbergs Markets, Acquisition, Meijer, Telephone, Financial result, Security (finance), Plant, Tops Friendly Markets, Depreciation, Health, Vitamin, Display, CEA, Growth, Ice Cream Cake (EP), Potato, Patent, Dr. Greenthumb, Walmart, Clothing, Retail, Video game, Cryptocurrency, Edible, Pulp

Mr. Jim Kras, Chief Executive Officer of Edible Garden, stated, "We are pleased to report year-over-year revenue growth of 19.4% for the third quarter of 2023.

Key Points: 
  • Mr. Jim Kras, Chief Executive Officer of Edible Garden, stated, "We are pleased to report year-over-year revenue growth of 19.4% for the third quarter of 2023.
  • Additionally, Edible Garden is enhancing its infrastructure and refining its data analytics capabilities, as we pursue opportunities to boost profit margins.
  • As an example, we partnered with Woodman’s Markets, which introduced Edible Garden produce and products to their 19 stores throughout Wisconsin and Illinois.
  • During the third quarter, Edible Garden introduced EG Direct, which is dedicated to sourcing and supplying partner-grown produce to its retail distribution network partners.

ClearPoint Neuro Reports Third Quarter 2023 Results

Retrieved on: 
Thursday, November 9, 2023
Brain, Interface (computing), Research, Telephone, Financial result, Investment, FDA, Paper, Software, Growth, Clothing, Generic drug, Medical device, Pharmaceutical industry, Video game

SOLANA BEACH, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced financial results for its third quarter ended September 30, 2023.

Key Points: 
  • SOLANA BEACH, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced financial results for its third quarter ended September 30, 2023.
  • “The third quarter was productive for the team as we continued to grow double digits while meaningfully reducing our operational cash burn,” commented Joe Burnett, President and CEO at ClearPoint Neuro.
  • “We believe that our long-term vision and strategy remain unchanged, however we are committed to focusing our near-term activities on profitable growth as our third quarter demonstrated.
  • Operating expenses for the third quarter of 2023 were $8.2 million, compared to $7.5 million for the third quarter of 2022.

Barnes & Noble Education Reports Second Quarter Fiscal Year 2024 Financial Results

Retrieved on: 
Wednesday, December 6, 2023
Technology, Retail, Office Products, Entertainment, Books, Online Retail, Continuing, University, Publishing, Primary, Secondary, Software, Education, Communications, Internet, Sale, NYSE, Autumn, Financial result, Barnes & Noble Education, Student, Consolidated, Faculty, GAAP, Adjustment, School, Growth, BNC, Continuous operation, Tourism, Video game, Management, Health care, Pharmaceutical industry, Nursing, Music

Barnes & Noble Education, Inc. (NYSE: BNED) , a leading solutions provider for the education industry, today reported sales and earnings for the second quarter ended on October 28, 2023.

Key Points: 
  • Barnes & Noble Education, Inc. (NYSE: BNED) , a leading solutions provider for the education industry, today reported sales and earnings for the second quarter ended on October 28, 2023.
  • Barnes & Noble Education is a highly seasonal business, and the second quarter includes the Fall rush period, which is historically the largest sales period for the Company.
  • The second quarter sales increase is primarily related to higher course material sales, primarily through the Company’s First Day programs.
  • Barnes & Noble Education expects to report fiscal year 2024 third quarter results in early March 2024.

Nu Holdings Ltd. Reports Third Quarter 2023 Financial Results

Retrieved on: 
Tuesday, November 14, 2023
Professional Services, Payments, Technology, Finance, Fintech, Banking, Social, Investment, Brazilian real, Conference, Analysis, Holding, Average cost method, Webcast, Ratio, International expansion of Netflix, ROE, Security (finance), International, NU, FX, INSS, Financial condition report, Result, Capital adequacy ratio, Acceleration, Insurance, IEP, Prospectus, Central Bank of Brazil, Asset quality, NPL, NYSE, Yoy, Financial result, Pix, Annual report, Phase 10, FXN, International Financial Reporting Standards, Cryptocurrency, Bank, Video game, Audit, Nu, Growth, Nubank, Payroll

Nu Holdings Ltd. (NYSE: NU), (“Nu” or the “Company”), one of the world’s largest digital financial services platforms, released today its Third Quarter 2023 financial results.

Key Points: 
  • Nu Holdings Ltd. (NYSE: NU), (“Nu” or the “Company”), one of the world’s largest digital financial services platforms, released today its Third Quarter 2023 financial results.
  • Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards (IFRS).
  • Below are the Q3’23 performance highlights of Nu Holdings Ltd.:
    Customer growth: Nu added 5.4 million customers in Q3’23 and 18.7 million year-over-year (YoY), reaching a total of 89.1 million customers globally by September 30, 2023.
  • Nu is the fourth-largest financial institution by number of customers in the country, according to Brazilian Central Bank data.

Bioceres Crop Solutions Reports Fiscal First Quarter 2024 Financial and Operational Results

Retrieved on: 
Monday, November 13, 2023
Agriculture, Natural Resources, Sustainability, Environment, Climate Change, Chemicals, Plastics, Green Technology, Manufacturing, EBITDA, Climate change, Yoy, Financial result, Seed, International, UBP, Genetically modified wheat, Weather, HB4, Growth, United States patent law, Patent, Soil, Face, International Financial Reporting Standards, Pharmaceutical industry

Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the first quarter ended September 30, 2023.

Key Points: 
  • Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the first quarter ended September 30, 2023.
  • Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards.
  • Total revenues in 1Q24 were $116.6 million, driven by post-drought recovery at the start of the Argentine summer crop season, and continued global expansion.
  • Mr. Federico Trucco, Bioceres’ Chief Executive Officer, commented: “The first quarter of fiscal 2023 was a record-setting quarter in which we nearly doubled revenues as compared to the prior year period.

The L.S. Starrett Company Announces Fiscal 2024 First Quarter Results

Retrieved on: 
Monday, November 13, 2023
Other Manufacturing, Construction & Property, Steel, Engineering, Automotive Manufacturing, Aerospace, Manufacturing, Machinery, Machine Tools, Metalworking & Metallurgy, Other Construction & Property, Table, NYSE, Financial result, GAAP, Face, Calendar, Brazilian real, Bank, Video game

Starrett Company (NYSE: SCX) (“Starrett” or “the Company”) a global innovator, manufacturer and marketer of precision measuring tools, cutting tools and equipment, and high-end metrology solutions for industrial, professional, and consumer markets, today announced operating results for the quarter ended September 30, 2023.

Key Points: 
  • Starrett Company (NYSE: SCX) (“Starrett” or “the Company”) a global innovator, manufacturer and marketer of precision measuring tools, cutting tools and equipment, and high-end metrology solutions for industrial, professional, and consumer markets, today announced operating results for the quarter ended September 30, 2023.
  • Gross margin for the quarter was 32.2%, a decline of 120 basis points from 33.4% in the first quarter of the prior year.
  • First quarter operating income was 4.1%, down 200 basis points, from 6.1% in the first quarter of the prior year.
  • First quarter diluted Earnings per Share was $0.25 compared to $0.27 for the first quarter in the prior fiscal year.